Increased level of soluble adenosine deaminase in bone marrow of visceral leishmaniasis patients: an inverse relation with parasite load
Adenosine deaminase (ADA) which degrades adenosine to inosine, is known to be pro-inflammatory molecule in many diseases. Adenosine suppresses the functioning of the immune system and thus promotes dissemination of the parasite. In our previous finding, the level of soluble ADA in serum of visceral leishmaniasis (VL) was found to be increased as compared to healthy controls. However, it cannot be fairly interpreted unless their level is demonstrated at the disease site, where the parasite resides. We designed this study to correlate the level of soluble ADA (sADA) with parasitic load at the disease site i.e. bone marrow (BM). We found increased levels of sADA in BM as compared to the unaffected BM. Furthermore, a significant inverse correlation is observed between the parasite load and level of sADA at the disease site.
KeywordsVisceral leishmaniasis bone marrow Adenosine deaminase Leishmania donovani
Unable to display preview. Download preview PDF.
- de Almeida Marques-da-Silva E., de Oliveira J.C., Figueiredo A.B., de Souza Lima Junior D., Carneiro C.M., Rangel Fietto J.L., Crocco Afonso L.C. 2008. Extracellular nucleotide metabolism in Leishmania: influence of adenosine in the establishment of infection. Microbes and Infection, 10, 850–7. DOI: 10.1016/j.micinf.2008.04.016CrossRefGoogle Scholar
- Hirschhorn R., Ratech H. 1980. Isozymes of adenosine deaminase. Isozymes Current Topics in Biological Medical Research, 4, 131–57Google Scholar
- Pinheiro C.M., Martins-Duarte E.S., Ferraro R.B., Fonseca de Souza A.L., Gomes M.T., Lopes A.H., Vannier-Santos M.A., Santos A.L., Meyer-Fernandes J.R. 2006. Leishmania amazonensis: Biological and biochemical characterization of ecto-nucleoside triphosphate diphosphohydrolase activities. Experimental Parasitology, 114, 16–25. DOI: 10.1016/j.exppara.2006.02.007CrossRefGoogle Scholar
- Roberts M.T. 2005. Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment. British Medical Bulletin, 115, 75–76. DOI: 10.1093/bmb/ldl003Google Scholar
- Sypek J.P., Chung C.L., Mayor S.E., Subramanyam J.M., Goldman S.J., Sieburth D.S., Wolf S.F., Schaub R.G. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. The Journal of Experimental Medicine, 177, 1797–802. DOI: 10.1084/jem.177.6.1797CrossRefGoogle Scholar
- Tripathi K., Kumar R., Bharti K., Kumar P., Shrivastav R., Sundar S., Pai K. 2008. Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India. Clinica Chimica Acta, International Journal of Clinical Chemistry, 388, 135–8. DOI: 10.1016/j.cca.2007.10.022CrossRefGoogle Scholar